Lisata Therapeutics, Inc.
LSTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000320017
No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $3.70M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Lisata Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −3 vs. Q4 2022
- Shares held
- 639.7K
- −85.2K (−11.8%) vs. Q4 2022
- Total value
- $2.08M
- +$245.1K (+13.4%) vs. Q4 2022
- New holders
- 1
- 2 more added
- Sold out
- 4
- 3 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LSTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $3.70M |
| Q1 2026 | 34 | $7.06M |
| Q4 2025 | 25 | $1.36M |
| Q3 2025 | 21 | $1.93M |
| Q2 2025 | 20 | $2.26M |
| Q1 2025 | 22 | $1.84M |
| Q4 2024 | 21 | $2.33M |
| Q3 2024 | 20 | $2.30M |
| Q2 2024 | 22 | $2.61M |
| Q1 2024 | 21 | $2.30M |
| Q4 2023 | 22 | $2.03M |
| Q3 2023 | 21 | $1.46M |
| Q2 2023 | 22 | $2.51M |
| Q1 2023 | 21 | $2.08M |
| Q4 2022 | 24 | $1.83M |
| Q3 2022 | 22 | $2.17M |
| Q2 2022 | 36 | $5.00M |
| Q1 2022 | 34 | $6.13M |
| Q4 2021 | 36 | $7.33M |
| Q3 2021 | 34 | $9.41M |
| Q2 2021 | 29 | $10.1M |
| Q1 2021 | 33 | $12.9M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Lisata Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Valley National Advisers Inc | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 52 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1 | $3 | 0.00% | −5,896−100.0% | Reduced |
| FMR LLC | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 3 | $9 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 6 | $19 | 0.00% | +2+50.0% | Added |
| Pacific Center for Financial Services | 8 | $26 | 0.00% | +8 | New |
| Northwestern Mutual Wealth Management Co | 20 | $65 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 26 | $84 | 0.00% | −20−43.5% | Reduced |
| Wells Fargo & Company | 29 | $94 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 691 | $2.00K | 0.00% | −905−56.7% | Reduced |
| Founders Capital Management | 666 | $2.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,549 | $5.03K | 0.00% | 00.0% | Unchanged |
| Cook Wealth Management Group LLC | 12,175 | $39.6K | 0.03% | 00.0% | Unchanged |
| State Street Corp | 14,348 | $46.6K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 14,951 | $48.6K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 25,973 | $84.4K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 56,806 | $184.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 92,422 | $300.0K | 0.00% | +300+0.3% | Added |
| Vanguard Group Inc | 176,139 | $571.6K | 0.00% | 00.0% | Unchanged |
| BML Capital Management, LLC | 243,839 | $791.3K | 0.68% | 00.0% | Unchanged |
| Sabby Management, LLC | 0 | $0 | 0.00% | −68,462−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −10,082−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −146−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −7−100.0% | Sold out |